Evaluation of the synergistic effect of curcumin in controlling urinary irritation symptoms after endoscopic benign prostatic hyperplasia in comparison with anticholinergic treatment alone

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170417033489N9

Enrollment

Registered

2021-11-03

Start date

2020-11-21

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia. hyperplasia of prostate (adenomatous)

Interventions

Intervention 1: Intervention group: They are treated with anticholinergics at a dose of one tablet twice a day and oral curcumin tablets once a day. After one month from the start of treatment, the re

Eligibility

Sex/Gender

Male

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with benign prostatic hyperplasia who have undergone endoscopic surgery and now have symptoms of urinary irritation.

Exclusion criteria

Exclusion criteria: Patients with severe preoperative irritation symptoms Existence of fever and symptoms of prostatitis Existence of bladder injury during surgery Existence of active urinary tract infection Having underlying diseases such as high blood pressure Glaucoma

Design outcomes

Primary

Measure	Time frame
Score obtained based on the patient's irritating symptoms questionnaire. Timepoint: Before the intervention and one month after taking curcumin. Method of measurement: International Prostate Symptom Score (IPSS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSalman Soltani

Mashhad University of Medical Sciences

soltanis@mums.ac.ir+98 51 3858 3885

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026